Taking on board COVID-19 vaccine approval euphoria plus growth prospects
30/12/20 -"With UK’s emergency use approval for Astra-Oxford’s COVID-19 vaccine candidate, the sentiment around Astra’s share price should improve finally. Besides taking on board the 100% probability of ..."
Pages
72
Language
English
Published on
30/12/20
You may also be interested by these reports :
27/01/21
We had expected Lonza’s FY 2020 release would be difficult to read, but the presentation of the figures with no helpful tables requires patience to ...
27/01/21
Novartis ended 2020 on a decent note, thanks to a sustained sales recovery momentum and impressive margin progression. While 2021 sales momentum is ...
26/01/21
Since our last Teaser in November 2019, it has been a roller-coaster ride for Sanofi (Buy, France). While an impressive mid-term growth strategy ...
30/12/20
With UK’s emergency use approval for Astra-Oxford’s COVID-19 vaccine candidate, the sentiment around Astra’s share price should improve finally. ...